Neoplastic meningitis-related encephalopathy: prognostic significance.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 15596770.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two cohorts of 20 patients diagnosed with neoplastic meningitis (NM) with or without encephalopathy were matched with respect to age, sex, primary tumor, and performance status. Median survival was 10 weeks (range 6 to 20 weeks) in the cohort with NM-related encephalopathy compared to 24 weeks (range 8 to 40 weeks) in the cohort without NM-related encephalopathy (p < 0.001). NM-related encephalopathy is a clinical variable that predicts for poor survival in patients with NM.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma
- Confusion
- Meningeal Neoplasms
- Meningitis, Aseptic